Skip to content
healthcare.dev

Yulithira

NDC 82249-610, Everolimus, tablet, from CivicaScript, LLC.

Product NDC
82249-610
Status
Listed
Labeler
CivicaScript, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205426
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82249-610 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS2.5 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
82249-610-308224906103030 TABLET in 1 BOTTLE (82249-610-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5e325efa-8ae6-4dac-b59b-d7c74c73186c

Use it

Look up 82249-610 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82249-610 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82249-610. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.